CompletedNCT02712463
A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics
Observational studyAges 18–55Brazil + Mexico
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- Aracaju and 10 more locationsSee all locations and recruitment
Study information
Study start dateJuly 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 310
- Sponsor
- Janssen-Cilag Ltd.
- Sponsor type
- Other organization
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Brazil, Mexico
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT02712463
- Official title
Show the full official title
A Retrospective, Observational Study to Assess the Rate of Hospitalization in Patients With Schizophrenia Treated One Year Before With Oral Antipsychotics and One Year After With Long Acting Injectable Atypical Antipsychotics - REALAI Study
Get this study by email
Recruitment & locations
CompletedAracaju, Brazil · Brasília, Brazil · Rio de Janeiro, Brazil
8 more locations
- São José, Brazil
- São Paulo, Brazil
- Durango, Mexico
- Hermosillo, Mexico
- Ixtapaluca, Mexico
- México, Mexico
- Monterrey, Mexico
- San Pedro Garza García, Mexico
Questions about this study
Who is behind this study?
The study sponsor is Janssen-Cilag Ltd.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
